Nearly 50 percent of Indian women are giving importance to their own preventive and diagnostic healthcare, which is a transformative shift in women's health-seeking behavior, according to a new report on Thursday.
DKSH’s Business Unit Performance Materials, a leading distributor of specialty chemicals and ingredients, will provide business development, marketing, sales, logistics, and distribution services for Lactalis’ pharmaceutical-grade lactose.
The government has recognized and accepted the industry's critical demand for PTUAS (Pharmaceutical Technology Upgradation Assistance Scheme) changes to better support improving quality standards, said Arunish Chawla.
A recent event on AI in Healthcare saw the introduction of a new theme, AI-driven innovation in Healthcare, expanding the discourse well beyond the technology’s role in EMR (electronic medical record) adoption, physician productivity.
Nethradhama Super Specialty Eye Hospitals performed the first refractive cataract surgery in India using Femtis Mplus. The latest innovation in ophthalmology is the paradigm-changing cataract surgery that combines defect correction.
As International Women's Day approaches, Clinics on Cloud, India's leading health tech company, unveils transformative insights into women's health, shedding light on the profound impact of accessible healthcare solutions.
Luye Pharma has launched Zepzelca (lurbinectedin), a new drug for treating SCLC in Hong Kong and Macau.
Shares of Sun Pharmaceutical Industries rose about 2%, hitting a 52-week high late on March 6, after the U.S. Food and Drug Administration (FDA) said it had granted full approval to Active Pharmaceutical Ingredient (API) from Ankleshwar Company).
The Indian healthcare innovation market is anticipated to reach an estimated $60 billion by FY 2028, with Indian companies increasingly leveraging emerging technologies to add innovation vectors, including new business models
Ayer AG and BlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly owned, independently operated subsidiary of Bayer AG, announced details of 18-month data from the phase I clinical trial for bemdaneprocel
, CDSCO.jpg)
